Sulaiman J, Thompson J, Qian Y, Vivas E, Diener C, Gibbons S
Nat Commun. 2024; 15(1):7416.
PMID: 39198411
PMC: 11358386.
DOI: 10.1038/s41467-024-51062-w.
Sulaiman J, Thompson J, Qian Y, Vivas E, Diener C, Gibbons S
bioRxiv. 2024; .
PMID: 38659900
PMC: 11042340.
DOI: 10.1101/2024.04.13.589383.
Jess A, Eskander G, Vu M, Michail S
Metabolites. 2023; 13(10).
PMID: 37887364
PMC: 10608736.
DOI: 10.3390/metabo13101039.
Yanckello L, Fanelli B, McCulloch S, Xing X, Sun M, Hammond T
J Cell Immunol. 2022; 4(2):50-64.
PMID: 35611116
PMC: 9126115.
DOI: 10.33696/immunology.4.132.
Jones J, Liu L, Rank L, Wetzel D, Woods E, Biok N
ACS Infect Dis. 2021; 7(5):1236-1247.
PMID: 33739823
PMC: 8130196.
DOI: 10.1021/acsinfecdis.0c00843.
Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?.
Lin Z, Iqbal Z, Ortiz J, Khan S, Jahan N
Cureus. 2020; 12(8):e9653.
PMID: 32923252
PMC: 7482981.
DOI: 10.7759/cureus.9653.
Patient Experiences with Infection: Results of a Canada-Wide Survey.
Vent-Schmidt J, Attara G, Lisko D, Steiner T
Patient Prefer Adherence. 2020; 14:33-43.
PMID: 32021115
PMC: 6954101.
DOI: 10.2147/PPA.S229539.
Regulation and Anaerobic Function of the β-Lactamase.
Sandhu B, Edwards A, Anderson S, Woods E, McBride S
Antimicrob Agents Chemother. 2019; 64(1).
PMID: 31611350
PMC: 7187622.
DOI: 10.1128/AAC.01496-19.
Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
Hui W, Li T, Liu W, Zhou C, Gao F
PLoS One. 2019; 14(1):e0210016.
PMID: 30673716
PMC: 6343888.
DOI: 10.1371/journal.pone.0210016.
Pomegranate extract specifically inhibits growth and toxin production without disturbing the beneficial bacteria in vitro.
Sukumar M, Konig B
Infect Drug Resist. 2018; 11:2357-2362.
PMID: 30532567
PMC: 6247965.
DOI: 10.2147/IDR.S163484.
Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.
Pakpour S, Bhanvadia A, Zhu R, Amarnani A, Gibbons S, Gurry T
Microbiome. 2017; 5(1):148.
PMID: 29132405
PMC: 5684761.
DOI: 10.1186/s40168-017-0368-1.
Second generation cephalosporin antibiotic prophylaxis and Clostridium difficile infection in hip and knee arthroplasty.
Al-Tawil K, Babu A, Loeffler M, Williams T
Ann R Coll Surg Engl. 2017; 99(5):351-354.
PMID: 28462657
PMC: 5449700.
DOI: 10.1308/rcsann.2017.0025.
A human gut ecosystem protects against C. difficile disease by targeting TcdA.
Martz S, Guzman-Rodriguez M, He S, Noordhof C, Hurlbut D, Gloor G
J Gastroenterol. 2016; 52(4):452-465.
PMID: 27329502
PMC: 5177537.
DOI: 10.1007/s00535-016-1232-y.
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.
Theriot C, Young V
Annu Rev Microbiol. 2015; 69:445-61.
PMID: 26488281
PMC: 4892173.
DOI: 10.1146/annurev-micro-091014-104115.
Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.
Moore J, Pinheiro C, Zaenker E, Bolick D, Kolling G, van Opstal E
PLoS One. 2015; 10(7):e0131829.
PMID: 26181795
PMC: 4504475.
DOI: 10.1371/journal.pone.0131829.
Recurrent Clostridium difficile infection and the microbiome.
Almeida R, Gerbaba T, Petrof E
J Gastroenterol. 2015; 51(1):1-10.
PMID: 26153514
DOI: 10.1007/s00535-015-1099-3.
Recurrent Clostridium difficile infection: From colonization to cure.
Shields K, Araujo-Castillo R, Theethira T, Alonso C, Kelly C
Anaerobe. 2015; 34:59-73.
PMID: 25930686
PMC: 4492812.
DOI: 10.1016/j.anaerobe.2015.04.012.
Treatment of infection: recent trial results.
Lewis S, Anderson D
Clin Investig (Lond). 2014; 3(9):875-886.
PMID: 25525499
PMC: 4267478.
DOI: 10.4155/cli.13.72.
Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
Bibbo S, Lopetuso L, Ianiro G, Di Rienzo T, Gasbarrini A, Cammarota G
J Immunol Res. 2014; 2014:462740.
PMID: 24995345
PMC: 4068057.
DOI: 10.1155/2014/462740.
Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology.
Sathyendran V, McAuliffe G, Swager T, Freeman J, Taylor S, Roberts S
Eur J Clin Microbiol Infect Dis. 2014; 33(10):1741-7.
PMID: 24810967
DOI: 10.1007/s10096-014-2139-2.